Drug Database
Back to search

Poland· PL-100326520

Velphoro

A sucroferric oxyhydroxide product containing ferrum iii, registered in Poland by Vifor Fresenius Medical Care Renal Pharma France. The same ATC class is registered in 12 of our 19 countries.

ATC V03AE05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVelphoroATCV03AE05REGISTER NO.PL-100326520PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ferrum iiiAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sucroferric oxyhydroxide is registered in 12 of 19 countries.

Countries holding a registration under ATC V03AE05 (sucroferric oxyhydroxide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search sucroferric oxyhydroxide products by name

Sucroferric oxyhydroxide · ATC V03AE05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sucroferric oxyhydroxide costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sucroferric oxyhydroxide · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.80
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ferrum III
Manufacturer
Vifor Fresenius Medical Care Renal Pharma France
Country
Poland (PL)
ATC code
V03AE05
ATC class
Sucroferric oxyhydroxide
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sucroferric oxyhydroxide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sucroferric oxyhydroxide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Belgium · Tardyneo, Tardysol
  • Bulgaria · Малтофер
  • Czechia · Ferric Carboxymaltose Teva
  • Germany · Carbofeo, Eisencarboxymaltose Al
  • Denmark · Feriliva, Ferofix
  • Estonia · Ferrum, Ferrum Lek
  • Spain · Carboximaltosa Férrica Teva
  • France · Carboxymaltose Ferrique Teva, Tardyferon Enfants Et Adultes
  • United Kingdom (Northern Ireland) · Galfer, Molcava
  • Greece · Ferric Carboxymaltose Teva, Tardy-Fer
  • Croatia · Ferrum, Friona Teva
  • Hungary · Vas (Iii)-Karboximaltóz
  • Ireland · Galfer
  • Italy · Carbossimaltosio Ferrico Mylan, Carbossimaltosio Ferrico Teva
  • Lithuania · Ferrum Lek, Tardyliq
  • Luxembourg · Tardyneo, Tardysol
  • Latvia · Ferrum Lek, Tardyliq
  • Malta · Ferrovin, Galfer
  • Netherlands · Ferrofumaraat Cf, Hemafer
  • Norway · Feriliva
  • Portugal · Carboximaltose Férrica Teva
  • Romania · Carboximaltoză Ferică Teva
  • Sweden · Feriliva, Ferofix
  • Slovenia · Ferrum Lek, Friona
  • Slovakia · Ferric Carboxymaltose Teva, Hemafer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8e2c5fbd-2e0f-43ad-93fb-1bdef66e9a30
GET /v1/drugs/8e2c5fbd-2e0f-43ad-93fb-1bdef66e9a30?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki do rozgryzania i żucia",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "Rp ¦ EU/1/14/943/002 ¦ 104275\n1 butelka 90 tabl.\nRp ¦ EU/1/14/943/001 ¦ 104276\n1 butelka 30 tabl.\nRp ¦ EU/1/14/943/003 ¦ 104277\n30 tabl. w blistrze\nRp ¦ EU/1/14/943/004 ¦ 104278\n90 tabl. w blistrze",
  "substance": "Żelazo w postaci cukrożelazowego tlenowodorotlenku 500 mg",
  "common_name": "Ferrum III",
  "pl_product_id": "100326520",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about sucroferric oxyhydroxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console